Effects of medium-chain fatty acids on the structure and immune response of IPEC-J2 cells

被引:0
|
作者
B. Martínez-Vallespín
W. Vahjen
J. Zentek
机构
[1] Freie Universität Berlin,Department of Veterinary Medicine, Institute of Animal Nutrition
来源
Cytotechnology | 2016年 / 68卷
关键词
Medium-chain fatty acids; IPEC-J2; Enteritidis;
D O I
暂无
中图分类号
学科分类号
摘要
Medium-chain fatty acids (MCFAs) have been suggested as an alternative to the use of antibiotics in animal nutrition with promising results. First, we studied the sensitivity of Salmonella Enteritidis and an enteropathogenic Escherichia coli strain against caprylic (C8), capric (C10) and lauric (C12) acids. A porcine in vitro model using the porcine cell line IPEC-J2 was used to test the effects of MCFAs on structural and immunological traits without and with a concomitant challenge with E. coli or S. Enteritidis. The three MCFAs exerted an inhibitory effect on bacterial growth, stronger for C12 than C8 or C10, S. Enteritidis being more sensitive than the E. coli strain. Flow cytometry showed a numeric concentration dependent increase in the adhesion of E. coli or S. Enteritidis to IPEC-J2 cells. Measurement of transepithelial electrical resistance after bacterial challenge showed negative effects of all MCFAs on IPEC-J2 cells at the highest concentrations. Immune parameters were affected by C8, since a concentration dependent effect starting at 5 mM was observed for mRNA expression of IL-6 and TLR-4 (up-regulated) and IL-8 (down-regulated). TLR-4 was up-regulated with C10 at 2 and 5 mM. The three MCFAs affected also the epithelial morphology through down-regulation of Occludin and up-regulation of Claudin-4 expression. In conclusion, the three MCFAs under study influenced bacterial growth rates and modified the gene expression to a different degree in the cell line IPEC-J2 but the effect on the morphological structure and response of the cells after bacterial challenge could not be assessed. Although these tests show a prior estimation of MCFAs effects in intestinal epithelium, in vivo confirmation is still needed.
引用
收藏
页码:1925 / 1936
页数:11
相关论文
共 50 条
  • [41] FUNGAL STRATEGIES FOR DETOXIFICATION OF MEDIUM-CHAIN FATTY-ACIDS
    KINDERLERER, JL
    INTERNATIONAL BIODETERIORATION & BIODEGRADATION, 1993, 32 (1-3) : 213 - 224
  • [42] Advances on medium-chain fatty acids synthesis in Escherichia coli
    Fang, Lixia
    Feng, Xueru
    Liu, Duo
    Han, Ziyi
    Liu, Mengxiao
    Hao, Xueyan
    Cao, Yingxiu
    CHINESE SCIENCE BULLETIN-CHINESE, 2022, 67 (25): : 3014 - 3023
  • [43] INTESTINAL TRANSPORT MECHANISMS OF MEDIUM-CHAIN FATTY-ACIDS
    BLOCH, R
    DENNHARD.R
    LORENZME.H
    LINGELBA.B
    PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 1972, : R22 - &
  • [44] Engineering Yarrowia lipolytica for production of medium-chain fatty acids
    Rutter, Charles D.
    Zhang, Shuyan
    Rao, Christopher V.
    APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, 2015, 99 (17) : 7359 - 7368
  • [45] Medium-chain Fatty Acids as Metabolic Therapy in Cardiac Disease
    François Labarthe
    Roselle Gélinas
    Christine Des Rosiers
    Cardiovascular Drugs and Therapy, 2008, 22 : 97 - 106
  • [46] Engineering Yarrowia lipolytica for production of medium-chain fatty acids
    Charles D. Rutter
    Shuyan Zhang
    Christopher V. Rao
    Applied Microbiology and Biotechnology, 2015, 99 : 7359 - 7368
  • [47] Effect of exercise and medium-chain fatty acids on postprandial lipemia
    Thomas, TR
    Horner, KE
    Langdon, MM
    Zhang, JQ
    Krul, ES
    Sun, GY
    Cox, RH
    JOURNAL OF APPLIED PHYSIOLOGY, 2001, 90 (04) : 1239 - 1246
  • [48] Role Medium-Chain Fatty Acids in the Lipid Metabolism of Infants
    Yuan, Tinglan
    Wang, Lei
    Jin, Jun
    Mi, Lijuan
    Pang, Jinzhu
    Liu, Zhengdong
    Gong, Jinyan
    Sun, Cong
    Li, Jufang
    Wei, Wei
    Jin, Qingzhe
    Wang, Xingguo
    FRONTIERS IN NUTRITION, 2022, 9
  • [49] THE ROLE OF MEDIUM-CHAIN FATTY ACIDS IN RENAL METABOLISM AND DISEASES
    Wu Yiting
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 : I1159 - I1160
  • [50] Medium-chain fatty acids as metabolic therapy in cardiac disease
    Labarthe, Francois
    Gelinas, Roselle
    Des Rosiers, Christine
    CARDIOVASCULAR DRUGS AND THERAPY, 2008, 22 (02) : 97 - 106